Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population

Background The modifications of cholesterol metabolism associated with aging are ill-defined. The objective of this study was to define age-associated alterations of the different metabolic pathways controlling cholesterol homeostasis by analyzing circulating sterols. Methods We analyzed serum samples collected from 201 adult (75 male, 126 female) subjects within the epidemiological MICOL study (Multicentrica Italiana Colelitiasi). The age range was 38–79 years; 103 had evidence of gallstones. The concentrations of the different sterols, recognized as markers of the main pathways of cholesterol homeostasis, were analyzed by gas chromatography-mass spectrometry, including lathosterol (synthesis), campesterol and sitosterol (absorption), and 7α-hydroxy-4-cholesten-3-one (degradation to bile acids). Results A significant direct correlation was detected between age and cholesterol levels (r =0.34, P<0.01). The lathosterol/cholesterol ratio was lower in older age quartiles (P<0.05 by analysis of variance), with an inverse correlation between the lathosterol/cholesterol ratio and age (r=−0.32, P<0.01). Such correlation was particularly evident in females. The campesterol/cholesterol and sitosterol/cholesterol ratios were inversely correlated with aging in control, but not in gallstone patients. The levels of 7α-hydroxy-4-cholesten-3-one were not correlated with age. Conclusion These data show a reduction of cholesterol synthesis with aging which is associated with increased circulating cholesterol levels. The finding might be related to a reduced metabolic need for cholesterol in advancing age, leading to a downregulation of the main mechanisms of cholesterol intake in the liver. A different age-related behavior was observed in gallstone-free versus gallstone patients regarding cholesterol absorption. The possible implications in terms of the pharmacological management of hypercholesterolemia in the elderly remain to be defined.

[1]  D. Papandreou,et al.  Role of diet on non-alcoholic fatty liver disease: An updated narrative review. , 2015, World journal of hepatology.

[2]  E. Mannarino,et al.  Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. , 2012, Life sciences.

[3]  B. Angelin,et al.  Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19 , 2011, Journal of internal medicine.

[4]  A. Hofman,et al.  Association Between Serum Cholesterol and Noncardiovascular Mortality in Older Age , 2011, Journal of the American Geriatrics Society.

[5]  G. Zuliani,et al.  Dyslipidemias in the older subject: features,significance and treatment dilemmas , 2011 .

[6]  T. Strandberg,et al.  Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age; a 17-year population study , 2011, Annals of medicine.

[7]  L. Ferrucci,et al.  Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  M. Ricchi,et al.  Correlation between plasma levels of 7α-hydroxy-4-cholesten-3-one and cholesterol 7α-hydroxylation rates in vivo in hyperlipidemic patients , 2008, Steroids.

[9]  C. Sama,et al.  Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). , 2008, World journal of gastroenterology.

[10]  C. Gabbi,et al.  Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans. , 2008, Current medicinal chemistry.

[11]  C. Gabbi,et al.  Changes in bile acid synthesis in gallstone disease: Cause, consequence, or neither? , 2007, Hepatology.

[12]  N. Mitro,et al.  Age‐related changes in bile acid synthesis and hepatic nuclear receptor expression , 2007, European journal of clinical investigation.

[13]  K. Alexander,et al.  Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. , 2007, The American journal of geriatric pharmacotherapy.

[14]  W. Aronow.  Management of hyperlipidemia with statins in the older patient , 2006, Clinical interventions in aging.

[15]  V. Pallottini,et al.  Modified HMG‐CoA reductase and LDLr regulation is deeply involved in age‐related hypercholesterolemia , 2006, Journal of cellular biochemistry.

[16]  P. Portincasa,et al.  Cholesterol gallstone disease , 2006, The Lancet.

[17]  W. Aronow.  Lipids and the Elderly , 2004, Reviews in Endocrine and Metabolic Disorders.

[18]  B. Singer,et al.  Increases in Serum Non‐High‐Density Lipoprotein Cholesterol May Be Beneficial in Some High‐Functioning Older Adults: MacArthur Studies of Successful Aging , 2004, Journal of the American Geriatrics Society.

[19]  J. Miquel,et al.  Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. , 2004, Gastroenterology.

[20]  S. Grundy.  Statin therapy in older persons: pertinent issues. , 2002, Archives of internal medicine.

[21]  R. Kronmal,et al.  Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[22]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[23]  S. Grundy,et al.  Cholesterol Lowering in the Elderly Population , 1999 .

[24]  K. Hotta,et al.  Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  M. Petroni,et al.  Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. , 1998, Journal of lipid research.

[26]  A. Menotti,et al.  Factors associated with gallstone disease in the MICOL experience , 1997, Hepatology.

[27]  K. Einarsson,et al.  Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. , 1997, Journal of hepatology.

[28]  L. Ferrucci,et al.  Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons , 1997, Annals of Internal Medicine.

[29]  C. Wells,et al.  Re: "Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)". , 1995, American journal of epidemiology.

[30]  K. Anderson,et al.  Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. , 1994, Journal of gerontology.

[31]  J. Dietschy,et al.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. , 1993, Journal of lipid research.

[32]  R. Messora,et al.  Effect of aging on cholesterol 7 alpha-hydroxylation in humans. , 1993, Journal of lipid research.

[33]  K. Einarsson,et al.  Hepatic cholesterol metabolism in cholesterol gallstone disease. , 1991, Journal of lipid research.

[34]  M. Eriksson,et al.  Influence of age on the metabolism of plasma low density lipoproteins in healthy males. , 1991, The Journal of clinical investigation.

[35]  J. Sjövall,et al.  Levels of 7α‐hydroxy‐4‐cholesten‐3‐one in plasma reflect rates of bile acid synthesis in man , 1988 .

[36]  H. Kempen,et al.  Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.

[37]  G. Medici,et al.  Effect of ursocholic acid on bile lipid secretion and composition. , 1986, Gastroenterology.

[38]  K. Einarsson,et al.  Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. , 1985, The New England journal of medicine.

[39]  M. Banach,et al.  Statin therapy in the elderly: a review. , 2010, Archives of gerontology and geriatrics.

[40]  S. Grundy,et al.  Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. , 1999, Archives of internal medicine.

[41]  A. Menotti,et al.  Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) , 1995, American journal of epidemiology.

[42]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.

[43]  J. Sjövall,et al.  Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. , 1988, FEBS letters.

[44]  A. Smerieri,et al.  Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid. , 1980, Journal of lipid research.